Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular epidemiology: new rules for new tools?

Domenico Franco Merlo1, Maria Pia Sormani, Paolo Bruzzi

  • 1Unit of Epidemiology and Biostatistics, Department of Epidemiology and Prevention, National Cancer Research Institute, Largo Rosanna Benzi, 10, 16132 Genova, Italy. franco.merlo@istge.it <franco.merlo@istge.it>

Mutation Research
|July 18, 2006
PubMed
Summary

Molecular epidemiology uses biomarkers to study disease causes. Rigorous validation of these biomarkers as cancer risk predictors is crucial but challenging in epidemiological research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

International journal of medical informatics·2026
Same author

Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.

Lancet (London, England)·2026
Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026

Area of Science:

  • Epidemiology
  • Genetics
  • Biomarker Research

Background:

  • Molecular epidemiology integrates biological markers with epidemiological data to investigate environmental and genetic factors in diseases, particularly cancer.
  • Biomarkers offer enhanced sensitivity, specificity, and earlier detection of carcinogenic exposures, aiding in understanding disease etiology and prevention.

Purpose of the Study:

  • To highlight the critical, yet underexplored, need for validating biomarkers as surrogate endpoints for cancer risk prediction.
  • To emphasize the challenges in applying validation principles from therapeutic research to epidemiological settings.

Main Methods:

  • The study discusses the principles of biomarker validation, drawing parallels with therapeutic research.
  • It identifies the limitations of traditional validation methods, such as randomized studies, in epidemiological contexts.

Related Experiment Videos

Main Results:

  • Biomarkers can improve etiologic research, individual risk assessment, and prevention strategies.
  • There is a significant gap in the rigorous validation of biomarkers for predicting cancer risk.

Conclusions:

  • The validation of biomarker surrogacy is essential before their use in individual or population-level risk prediction.
  • Further exploration of validation methodologies is needed for epidemiological research to ensure reliable biomarker application.